CNI-Free Protocol in Kidney Transplant Recipients From Donors After Cardiac Death: Good Renal Function But High Incidence of Conversion to CNI

被引：0
|
作者：
Sanchez-Escuredo, A. [1 ]
Diekmann, F. [1 ]
Revuelta, I. [1 ]
Esforzado, N. [1 ]
Ricart, M. [1 ]
Cof, F. [1 ]
Torregrosa, V. [1 ]
Peri, L. [1 ]
Campistol, J. [1 ]
Oppenheimer, F. [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C1847
引用
收藏
页码：594 / 595
页数：2
相关论文
共 50 条
  • [21] EARLY CONVERSION TO A CNI-FREE IMMUNOSUPPRESSION WITH SRL AFTER RENAL TX - LONGTERM DATA OF A MULTICENTER TRIAL AND IMPLICATIONS FOR DNDSA
    Andrassy, J.
    Guba, M.
    Habicht, A.
    Pascher, A.
    Heller, K.
    Banas, B.
    Hakenberg, O.
    Vogel, T.
    Werner, J.
    Kauke, T.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 31 - 31
  • [22] IMMUNOSUPPRESSION WITH BELATACEPT-BASED, CNI-FREE, STEROID-AVOIDING REGIMENS IN KIDNEY TRANSPLANT RECIPIENTS: 6 MONTH, INTERIM RESULTS
    Grinyo, J. M.
    Marks, W.
    Vincenti, F.
    Kaufman, D.
    Marder, B.
    Woodle, S.
    Citterio, F.
    Agarwal, M.
    Garg, P.
    Lin, C. -S.
    Ferguson, R.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 90 - 91
  • [23] Late Conversion from CNI to mTOR Inhibitors Rather Preserves than Improves Renal Function in Kidney Allograft Recipients
    Ivanovski, N.
    Beaudreuil, S.
    Jacquet, A.
    Seidowski, A.
    Matesan, R.
    Obada, Nnang E.
    Hebibi, H.
    Charpantier, B.
    Durrbach, A.
    Francois, H.
    TRANSPLANTATION, 2012, 94 (10) : 1001 - 1001
  • [24] GLUCOSE METABOLISM FOLLOWING CONVERSION FROM CNI TO SIROLIMUS BASED IMMUNOSUPRESSION IN STABLE RENAL TRANSPLANT RECIPIENTS
    Kamaraj, Kam
    Baboolal, Keshwar
    TRANSPLANT INTERNATIONAL, 2009, 22 : 120 - 120
  • [25] An open, single centre, prospective study to investigate a steroid free immunosuppressive regimen for de novo renal transplant recipients followed by a two arm randomisation to a CNI-sparing and a CNI-free maintenance immunosuppression after 3 months
    Oetti, T.
    Descoeudres, B.
    Burkhalter, F.
    Bachmann, A.
    Guerke, L.
    Mihatsch, M. J.
    Dickenmann, M.
    Steiger, J.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 15S - 15S
  • [26] Conversion of CNI-To-Everolimus Immunosupression in Low Risk Renal Transplant Recipients Is Associated with Improved Allograft Function
    Cheng, V. E.
    Mathew, M.
    Gock, H.
    TRANSPLANTATION, 2012, 94 (10) : 963 - 963
  • [27] Immediate conversion from CNI to everolimus in kidney graft recipients using a "stop-and-go" protocol
    Pohanka, Erich
    Kodras, Katharina
    Kanzler, Marina
    Neumann, Irmgard
    Klauser-Braun, Renate
    Graf, Helmut
    Kovarik, Josef
    TRANSPLANT INTERNATIONAL, 2007, 20 : 131 - 132
  • [28] CNI-FREE DE NOVO "BOTTOM-UP, ON DEMAND" IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS WITH PREEXISTING RENAL IMPAIRMENT: AN INITIAL EXPERIENCE
    Schnitzbauer, Andreas A.
    Doenecke, Axel
    Sothmann, Johannes
    Loss, Martin
    Farkas, Stefan A.
    Zuelke, Carl
    Scherer, Marcus N.
    Schlitt, Hans J.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 236 - 236
  • [29] Immunosuppression with Belatacept-Based, CNI-Free, Steroid-Avoiding Regimens in Kidney Transplant Recipients: 6 Month, Interim Results.
    Grinyo, J. M.
    Marks, W.
    Vincenti, F.
    Kaufman, D. B.
    Marder, B. A.
    Woodle, S.
    Citterio, F.
    Agarwal, M.
    Garg, P.
    Lin, C. -S.
    Ferguson, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 382 - 382
  • [30] EARLY CONVERSION TO A CNI-FREE IMMUNOSUPPRESSION WITH SRL AFTER RENAL TX - LONGTERM DATA OF A MULTICENTER TRIAL AND IMPLICATIONS FOR THE PRODUCTION OF DNDSA
    Andrassy, J.
    Guba, M.
    Habicht, A.
    Pascher, A.
    Heller, K.
    Banas, B.
    Hakenberg, O.
    Vogel, T.
    Werner, J.
    Kauke, T.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 19 - 19
12345